focus -WSS

focus

author：comprehensive 2025-09-29 22:49:44 - browse：25785

Cathy McMorris Rodgers — hospitals coverage from STAT — House Energy & Commerce Chair Cathy McMorris Rodgers (R-Wash.) Kevin Dietsch/Getty Images

WASHINGTON — A House subcommittee will next week mark up a package of public health bills, including pandemic-preparedness legislation, according to five lobbyists.

The House Energy & Commerce Committee hasn’t yet announced the markup, and the lobbyists didn’t know the exact date. But time is running out for reauthorizing a law that created several of the federal government’s biodefense and pandemic-preparedness programs.

The Pandemic All-Hazards Preparedness Act was enacted in 2006 to help the government respond to nuclear and biological weapons, naturally occurring threats like avian influenza, and natural disasters. Those programs include the Administration for Strategic Preparedness and Response, which runs the country’s stockpile of medical supplies and coordinates responses to pandemics and other national emergencies, and the Biomedical Advanced Research and Development Authority, which promotes development of medical products that defend against those threats.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Medicare bonuses could stop drug shortages under Senate plan

hotspot

WSS

Dog Aging Project founders on what lies ahead after losing funding

What causes osteoarthritis? Researchers study link to brain protein

ASCO: Palliative care found as helpful given virtually as in person

Ionis drug prevents swelling attacks due to hereditary angioedema

Maisha Meds is a PBM, but don't call it that

ASCO: AstraZeneca's hat trick, and palliative care's spotlight

hotspot

focus

focus

Medical records are filled with copy

Ultragenyx gene therapy for rare liver ailment succeeds in late

In age of alternative facts, a scholarly course on calling out crap

Maisha Meds is a PBM, but don't call it that

Jerome Adams on the need for new antivirals for Covid

There's an unseen cost to disruptive road

The cancer drug shortage isn’t new — and neither are the solutions

Head of FDA's diagnostics center, who led through Covid, retires

Continuity nursing helped my family in our darkest PICU moments

Printout prescription drug information shouldn’t go digital

leisure time

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

Change Healthcare can notify patients about the breach, HHS says

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

Let's speed up science by embracing open access publishing

With trial win, GSK could get blood cancer drug back on market

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

Wikipedia

focus

hotspot

explore